The Precision Peptide Company Inc.
PNGAF
$0.34
-$0.01-1.48%
OTC PK
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -87.98% | -639.97% | -594.47% | -772.80% | -11.72% |
| Total Depreciation and Amortization | -- | -- | 1,485.71% | 3,733.33% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | 4,693.02% | -220.08% | -- |
| Change in Net Operating Assets | -48.90% | 323.08% | -294.63% | 1,117.20% | -341.62% |
| Cash from Operations | -59.71% | -226.58% | -710.83% | -430.86% | -661.27% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 68.30% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 68.30% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | 461.80% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 74.40% | -92.16% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 86.25% | -91.91% | -16.97% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 662.53% | -903.59% | -664.03% | 18,050.00% | 10.02% |